Approval · Notice of Compliance 20794 · 2018
FINASTERIDE: Notice of Compliance 20794
Issued April 26, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20794
- Date
- April 26, 2018
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update (to match licensor)
- Canadian reference product
- PROSCAR
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FINASTERIDE | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB